BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32872229)

  • 1. Mouse WIF1 Is Only Modified with
    Pennarubia F; Pinault E; Al Jaam B; Brun CE; Maftah A; Germot A; Legardinier S
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POFUT1-mediated O-fucosylation of glycoproteins expressed in the baculovirus Sf9 insect cell expression system.
    Haymour L; Pennarubia F; Le Faou CC; Pinault E; Germot A; Maftah A; Legardinier S
    J Biotechnol; 2024 Jan; 379():53-64. PubMed ID: 38070779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The single EGF-like domain of mouse PAMR1 is modified by O-Glucose, O-Fucose and O-GlcNAc.
    Pennarubia F; Germot A; Pinault E; Maftah A; Legardinier S
    Glycobiology; 2021 Jan; 31(1):55-68. PubMed ID: 32518939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin type-1 repeats by protein O-fucosyltransferases 1 and 2.
    Al-Shareffi E; Chaubard JL; Leonhard-Melief C; Wang SK; Wong CH; Haltiwanger RS
    Glycobiology; 2013 Feb; 23(2):188-98. PubMed ID: 23045360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-fucosylation of the notch ligand mDLL1 by POFUT1 is dispensable for ligand function.
    Müller J; Rana NA; Serth K; Kakuda S; Haltiwanger RS; Gossler A
    PLoS One; 2014; 9(2):e88571. PubMed ID: 24533113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct pathways for O-fucosylation of epidermal growth factor-like or thrombospondin type 1 repeats.
    Luo Y; Nita-Lazar A; Haltiwanger RS
    J Biol Chem; 2006 Apr; 281(14):9385-92. PubMed ID: 16464858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fringe modifies O-fucose on mouse Notch1 at epidermal growth factor-like repeats within the ligand-binding site and the Abruptex region.
    Shao L; Moloney DJ; Haltiwanger R
    J Biol Chem; 2003 Mar; 278(10):7775-82. PubMed ID: 12486116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of EGF-like domains by the Notch-modifying O-fucosyltransferase POFUT1.
    Li Z; Han K; Pak JE; Satkunarajah M; Zhou D; Rini JM
    Nat Chem Biol; 2017 Jul; 13(7):757-763. PubMed ID: 28530709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a GDP-L-fucose:polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains.
    Wang Y; Lee GF; Kelley RF; Spellman MW
    Glycobiology; 1996 Dec; 6(8):837-42. PubMed ID: 9023546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro acellular method to reveal O-fucosylation on EGF-like domains.
    Pennarubia F; Pinault E; Maftah A; Legardinier S
    Glycobiology; 2018 Nov; ():. PubMed ID: 30496416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: production of O-fucosylated epidermal growth factor domains.
    Chigira Y; Oka T; Okajima T; Jigami Y
    Glycobiology; 2008 Apr; 18(4):303-14. PubMed ID: 18252777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evolution of protein O-fucosyltransferase genes and splice variants.
    Loriol C; Dupuy F; Rampal R; Dlugosz MA; Haltiwanger RS; Maftah A; Germot A
    Glycobiology; 2006 Aug; 16(8):736-47. PubMed ID: 16679357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase.
    Wang Y; Shao L; Shi S; Harris RJ; Spellman MW; Stanley P; Haltiwanger RS
    J Biol Chem; 2001 Oct; 276(43):40338-45. PubMed ID: 11524432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and transportation pathways of GDP-fucose that are required for the O-fucosylation of Notch.
    Yamakawa T; Ayukawa T; Matsuno K
    Adv Exp Med Biol; 2012; 727():37-46. PubMed ID: 22399337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly conserved O-fucose sites have distinct effects on Notch1 function.
    Rampal R; Arboleda-Velasquez JF; Nita-Lazar A; Kosik KS; Haltiwanger RS
    J Biol Chem; 2005 Sep; 280(37):32133-40. PubMed ID: 15994302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WIF domain of the human and Drosophila Wif-1 secreted factors confers specificity for Wnt or Hedgehog.
    Sánchez-Hernández D; Sierra J; Ortigão-Farias JR; Guerrero I
    Development; 2012 Oct; 139(20):3849-58. PubMed ID: 22951645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling in normal and disease States: possible therapies related to glycosylation.
    Rampal R; Luther KB; Haltiwanger RS
    Curr Mol Med; 2007 Jun; 7(4):427-45. PubMed ID: 17584081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fringe GlcNAc-transferases differentially extend O-fucose on endogenous NOTCH1 in mouse activated T cells.
    Matsumoto K; Kumar V; Varshney S; Nairn AV; Ito A; Pennarubia F; Moremen KW; Stanley P; Haltiwanger RS
    J Biol Chem; 2022 Jul; 298(7):102064. PubMed ID: 35623385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-linked fucose is present in the first epidermal growth factor domain of factor XII but not protein C.
    Harris RJ; Ling VT; Spellman MW
    J Biol Chem; 1992 Mar; 267(8):5102-7. PubMed ID: 1544894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.